Longeveron

$6.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.62 (-8.68%) Today
+$0.13 (+1.99%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Longeveron and other stocks, options, and ETFs commission-free!

About LGVN

Longeveron Inc. Class A Common Stock, also called Longeveron, is a clinical stage biotechnology company that engages in the development of cellular therapies for specific aging-related and life-threatening conditions.

CEO
Geoff Green
Employees
12
Headquarters
Miami, Florida
Founded
2014
Market Cap
126.72M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.08M
High Today
$7.09
Low Today
$6.46
Open Price
$7.09
Volume
285.20K
52 Week High
$12.48
52 Week Low
$5.62

LGVN Earnings

Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, Pre-Market

You May Also Like

FXA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure